Abstract:Background Glucosamine 6-phosphate N -acetyltransferase (GNPNAT1) is a key enzyme in the hexosamine biosynthetic pathway (HBP), which functions as promoting proliferation in some tumors, yet its potential biological function and mechanism in lung adenocarcinoma (LUAD) have not been explored. Methods The mRNA differential expression of GNPNAT1 in LUAD and normal tissues was analyzed using the Cancer Genome Atlas (TCGA) database and validated by real-time PCR. The clinical value of GNPNAT1 in LUAD was investigated based on the data from the TCGA database. Then, immunohistochemistry (IHC) of GNPNAT1 was applied to verify the expression and clinical significance in LUAD from the protein level. The relationship between GNPNAT1 and epigenetics was explored using the cBioPortal database, and the miRNAs regulating GNPNAT1 were found using the miRNA database. The association between GNPNAT1 expression and tumor-infiltrating immune cells in LUAD was observed through the Tumor IMmune Estimation Resource (TIMER). Finally, Gene set enrichment analysis (GSEA) was used to explore the biological signaling pathways involved in GNPNAT1 in LUAD. Results GNPNAT1 was upregulated in LUAD compared with normal tissues, which was verified through qRT-PCR in different cell lines ( P < 0.05), and associated with patients’ clinical stage, tumor size, and lymphatic metastasis status (all P < 0.01). Kaplan–Meier (KM) analysis suggested that patients with upregulated GNPNAT1 had a relatively poor prognosis ( P < 0.0001). Furthermore, multivariate Cox regression analysis indicated that GNPNAT1 was an independent prognostic factor for LUAD (OS, TCGA dataset: HR = 1.028, 95% CI : 1.013–1.044, P < 0.001; OS, validation set: HR = 1.313, 95% CI : 1.130–1.526, P < 0.001). GNPNAT1 overexpression was correlated with DNA copy amplification ( P < 0.0001), low DNA methylation ( R = −0.52, P < 0.0001), and downregulation of hsa-miR-30d-3p ( R = −0.17, P < 0.001). GNPNAT1 expression was linked to B cells ( R = −0.304, P < 0.0001), CD4 + T cells ( R = −0.218, P < 0.0001), and dendritic cells ( R = −0.137, P = 0.002). Eventually, GSEA showed that the signaling pathways of the cell cycle, ubiquitin-mediated proteolysis, mismatch repair and p53 were enriched in the GNPNAT1 overexpression group. Conclusion GNPNAT1 may be a potential prognostic biomarker and novel target for intervention in LUAD.

Abnormally High Expression of DNAJB6 Accelerates Malignant Progression of Lung Adenocarcinoma

High Expression of JMJD6 Predicts Unfavorable Survival in Lung Adenocarcinoma

Comprehensive Analyses of Molecular Features, Prognostic Values, and Regulatory Functionalities of M6a-Modified Long Non-Coding RNAs in Lung Adenocarcinoma.

A Five-M6a Regulatory Gene Signature is a Prognostic Biomarker in Lung Adenocarcinoma Patients

Comprehensive Analysis of the Immune and Prognostic Implication of COL6A6 in Lung Adenocarcinoma

m6A-binding protein IGF2BP1 promotes the malignant phenotypes of lung adenocarcinoma

Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.

ZNF692 Promotes Proliferation and Cell Mobility in Lung Adenocarcinoma

The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma

DLX1 acts as a novel prognostic biomarker involved in immune cell infiltration and tumor progression in lung adenocarcinoma

DDX18 Facilitates the Tumorigenesis of Lung Adenocarcinoma by Promoting Cell Cycle Progression through the Upregulation of CDK4

GEMIN6 Overexpression Correlates with the Low Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma

Identification ofLBX2as a novel causal gene of lung adenocarcinoma

HSD17B6 Downregulation Predicts Poor Prognosis and Drives Tumor Progression Via Activating Akt Signaling Pathway in Lung Adenocarcinoma

Comprehensive analysis of the prognostic role and mutational characteristics of m6A-related genes in lung adenocacinoma

Comprehensive analysis identifies ARHGEF6 as a potential prognostic and immunological biomarker in lung adenocarcinoma

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma

Junctional Adhesion Molecule-Like Protein (JAML) is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma

Comprehensive Bioinformatics Analysis to Identify the Gene HMMR Associated with Lung Adenocarcinoma Prognosis and Its Mechanism of Action in Multiple Cancers.

Increased Expression of KNSTRN in Lung Adenocarcinoma Predicts Poor Prognosis: A Bioinformatics Analysis Based on TCGA Data

DMBX1 Promotes Tumor Proliferation and Regulates Cell Cycle Progression Via Repressing OTX2-mediated Transcription of P21 in Lung Adenocarcinoma Cell.